Show simple item record

YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

dc.contributor.authorGarmendia, I.
dc.contributor.authorPajares, M. J.
dc.contributor.authorHermida Prado, Francisco José 
dc.contributor.authorAjona, D.
dc.contributor.authorRodrigo Tapia, Juan Pablo 
dc.contributor.authorGarcía Pedrero, Juana María 
dc.date.accessioned2020-01-23T08:17:33Z
dc.date.available2020-01-23T08:17:33Z
dc.date.issued2019
dc.identifier.citationAmerican Journal of Respiratory and Critical Care Medicine, 200(7), p. 888-899 (2019); doi:10.1164/rccm.201807-1292OC
dc.identifier.issn1073-449X
dc.identifier.urihttp://hdl.handle.net/10651/53747
dc.description.statementofresponsibilityGarmendia, I; Pajares, MJ; Hermida-Prado, F; Ajona, D; Bertolo, C; Sainz, C; Lavin, A; Remirez, AB; Valencia, K; Moreno, H; Ferrer, I; Behrens, C; Cuadrado, M; Paz-Ares, L; Bustelo, XR; Gil-Bazo, I; Alameda, D; Lecanda, F; Calvo, A; Felip, E; Sanchez-Cespedes, M; Wistuba, II; Granda-Diaz, R; Rodrigo, JP; Garcia-Pedrero, JM; Pio, R; Montuenga, LM; Agorreta, J.
dc.format.extentp. 888-899
dc.language.isoeng
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicine
dc.rights© 2019 by the American Thoracic Society
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85072747188&doi=10.1164%2frccm.201807-1292OC&partnerID=40&md5=51314bdea4826fe69cfd0b97748ecbad
dc.titleYES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1164/rccm.201807-1292OC
dc.type.dcmitext
dc.relation.publisherversionhttp://dx.doi.org/10.1164/rccm.201807-1292OC
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record